Placenta
Volume 28 , Pages S23-S32 , April 2007

Dual In Vitro Perfusion of an Isolated Cotyledon as a Model to Study the Implication of Changes in the Third Trimester Placenta on Preeclampsia

  • S. Di Santo

      Affiliations

    • Department of Obstetrics and Gynecology, Universitäts-Frauenklinik, Inselspital, Effinger Strasse 102, CH 3010 Berne, Switzerland
  • ,
  • R. Sager

      Affiliations

    • Department of Obstetrics and Gynecology, Universitäts-Frauenklinik, Inselspital, Effinger Strasse 102, CH 3010 Berne, Switzerland
  • ,
  • A.-C. Andres

      Affiliations

    • Department of Clinical Research, University Berne, Berne, Switzerland
  • ,
  • S. Guller

      Affiliations

    • Department of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
  • ,
  • H. Schneider

      Affiliations

    • Department of Obstetrics and Gynecology, Universitäts-Frauenklinik, Inselspital, Effinger Strasse 102, CH 3010 Berne, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 (0)31 961 7430.

,Accepted 15 January 2007.

References 

  1. Hung T, Skepper J, Burton G. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol. 2001;159:1031–1043
  2. Hung T, Skepper J, Charnock-Jones D, Burton G. Hypoxia/reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002;90:1274–1281
  3. Di Santo S, Malek A, Sager R, Andres A, Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7–24h. Placenta. 2003;24:882–894
  4. Cannell G, Kluck R, Hamilton S, Mortimer R, Hooper W, Dickinson R. Markers of physical integrity and metabolic viability of the perfused human placental lobule. Clin Exp Pharmacol Physiol. 1988;15:837–844
  5. Miller R, Wier P, Shah Y, Sant'Agnese PD, D'Gregorio R. Criteria for in vitro dual perfusions in the human placental lobule: perfusions in excess of 12h. In:  Genbacev O,  Klopper A,  Beaconsfiled R editor. Placenta as a model and a source. New York: Plenum Press; 1989;p. 27–38
  6. Guller S., Ma Y., Malek A., Di Santo S., Schneider H. Differential release of plasminogen activators during dual perfusion of human placenta: implications in preeclampsia. Placenta 2006 Jul 3 [Epub ahead of print].
  7. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium, and leucine. Am J Obstet Gynecol. 1972;114:822–828
  8. vanWijk M, Nieuwland R, Boer K, van der Post J, VanBavel E, Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?. Am J Obstet Gynecol. 2002;187:450–456
  9. Redman C, Sargent I. Placental debris, oxidative stress and preeclampsia. Placenta. 2000;21:597–602
  10. Sargent I, Germain S, Sacks G, Kumar S, Redman C. Trophoblast deportation and the maternal inflammatory response in preeclampsia. J Reprod Immunol. 2003;59:153–160
  11. Hubel C. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222–235
  12. Schneider H. Placental oxygen consumption. Part II: in vitro studies—a review. Placenta. 2000;21(Suppl. A):S38–S44
  13. Challier J, Schneider H, Dancis J. In vitro perfusion of human placenta V. Oxygen consumption. Am J Obstet Gynecol. 1976;6:261–265
  14. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:369–382
  15. Poston L, Raijmakers M. Trophoblast oxidative stress, antioxidants and pregnancy outcome-a review. Placenta. 2004;25(Suppl. A):S72–S78
  16. Chappell L, Seed P, Briley A, Kelly F, Hunt B, Charnock-Jones D, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002;187:127–136
  17. Raijmakers M, Peters W, Steegers E, Poston L. NAD(P)H oxidase associated superoxide production in human placenta from normotensive and pre-eclamptic women. Placenta. 2004;25(Suppl. A):S85–S89
  18. Cui X, Brockman D, Campos B, Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta. 2006;27:422–431
  19. Myatt L, Rosenfied RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 1996;28:488–493
  20. Many A, Hubel C, Fisher S, Roberts J, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol. 2000;156:321–331
  21. Cester N, Staffolani R, Rabini R, Magnanelli R, Salvolini E, Galassi R, et al. Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes. Mol Cell Biochem. 1994;131:51–55
  22. Walsh S, Vaughan J, Wang Y, Roberts LN. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000;1289–1296
  23. Kim Y, Kim C, Cho M, Kim K, Lee S, Ahn B, et al. Total peroxyl radical-trapping ability and anti-oxidant vitamins in umbilical veinous plasma and the placental in preeclampsia. J Obstet Gynaecol Res. 2006;32:32–41
  24. Kay H, Tsoi S, Grindle K, Magness R. Markers of oxidative stress in placental villi exposed to ethanol. J Soc Gynecol Investig. 2006;13:118–121
  25. Estelles A, Gilabert J, Aznar J, Loskutoff D, Schleef R. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood. 1989;74:1332–1338
  26. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, et al. Altered expression of plasmonogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine growth retardation. Blood. 1994;84:143–150
  27. Jauniaux E, Watson A, Bao Y, Hempstock J, Skepper J, Burton G. Onset of maternal arterial blood flow and placental oxidative stress. Am J Pathol. 2000;157:2111–2122
  28. Hempstock J, Bao Y, Bar-Isaac M, Segaren N, Watson A, Charnock-Jones D, et al. Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial blood flow within the human placenta. Placenta. 2003;24:517–523
  29. Wang Y, Walsh S. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta. 2001;22:206–212
  30. Malek A, Sager R, Schneider H. Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta. 2001;22(Suppl. A):S45–S50
  31. Redman C, Sargent I. Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta. 2003;24:S21–S27
  32. Knight M, Redman C, Linton E, Sargent I. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105:632–640
  33. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003;59:277–287
  34. Smarason A, Sargent I, Starkey P, Redman C. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol. 1993;100:943–949
  35. Cockell A, Learmont J, Smarason A, Redman C, Sargent I, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol. 1997;104:235–240
  36. vanWijk M, Svedas E, Boer K, Nieuwland R, Vanbavel E, Kublickiene K. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol. 2002;187:1686–1693
  37. Sacks G, Studena K, Sargent I, Redman C. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80–86
  38. Redman C, Sacks G, Sargent I. Preeclampsia an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499–506
  39. von Dadelszen P, Magee L, Marshall J, Rotstein O. The maternal syndrome of preeclampsia: a forme fruste of the systemic inflammatory response syndrome. Sepsis. 2000;4:43–47
  40. Aly A, Khandelwal M, Zhao J, Mehmet A, Sammel M, Parry S. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol. 2004;190:252–258
  41. Goswami D, Tannetta D, Magee L, Fuchisawa A, Redman C, Sargent I, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset preeclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;56–61
  42. Huppertz B, Kingdom J, Caniggia I, Desoye G, Black S, Knorr H, et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta. 2003;24:181–190
  43. Huppertz B, Kingdom J. Apoptosis in the trophoblast – role of apoptosis in placental morphogenesis. J Soc Gynecol Invest. 2004;11:353–362
  44. Gupta A, Holzgreve W, Huppertz B, Malek A, Schneider H, Hahn S. Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem. 2004;50:2187–2190
  45. Gupta A, Rusterholz C, Huppertz B, Malek A, Schneider H, Holzgreve W, et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta. 2005;26:59–66
  46. Mellembakken J, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V. Chemokines and leucocyte activation in the fetal circulation during preeclampsia. Hypertension. 2001;38:394–398
  47. Davidge S, Signorella A, Lykins D, Gilmour C, Roberts J. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol. 1996;175:1301–1306
  48. Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S, et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005;90:4299–4308

PII: S0143-4004(07)00012-4

doi: 10.1016/j.placenta.2007.01.009

Placenta
Volume 28 , Pages S23-S32 , April 2007